Quanterix Corporation Accounts Receivables 2011-2026 | QTRX

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.

Examples of accounts receivable

Customers have not paid invoices for delivered products
An advance has been paid to a supplier, but goods have not yet been received
Employees have not reported on accountable amounts
The government must refund tax overpayments
Outstanding loans issued

Importance of accounts receivable in company analysis

Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)

Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)

If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables Quanterix Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30 M	32.1 M	25.4 M	19 M	23.8 M	17.2 M	10.9 M	6.79 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
32.1 M	6.79 M	20.7 M

Quarterly Accounts Receivables Quanterix Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
33 M	23.5 M	28.3 M	32.1 M	-	31.8 M	29.3 M	25.4 M	24.4 M	22.5 M	19 M	18.3 M	19.7 M	22.6 M	23.8 M	18.4 M	15.4 M	14.9 M	17.2 M	17.2 M	17.2 M	17.2 M	10.9 M	150 K	150 K	150 K	150 K	150 K	150 K	150 K	5.6 M	5.6 M	5.6 M	5.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
33 M	150 K	15.3 M

Accounts Receivables of other stocks in the Medical devices industry

Issuer	Accounts Receivables	Price	% 24h	Market Cap	Country
BioSig Technologies BSGM	109 K	-	37.08 %	$ 85.7 M	USA
Axonics Modulation Technologies AXNX	44.8 M	-	-	$ 3.31 B	USA
Xtant Medical Holdings XTNT	20.7 M	$ 0.55	-2.31 %	$ 73.5 M	USA
Dynatronics Corporation DYNT	2.8 M	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	1.73 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	11.4 M	-	-26.83 %	$ 2.62 M	USA
Zimmer Biomet Holdings ZBH	1.48 B	$ 88.57	-0.65 %	$ 18 B	USA
Allied Healthcare Products AHPI	2.37 M	-	3.58 %	$ 2.21 M	USA
Alphatec Holdings ATEC	97.3 M	$ 10.93	-5.12 %	$ 1.64 B	USA
Conformis CFMS	9.77 M	-	-	$ 16.4 M	USA
Accuray Incorporated ARAY	83.2 M	$ 0.4	4.21 %	$ 41.1 M	USA
Cardiovascular Systems CSII	39.7 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	455 K	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	15 M	-	-	$ 475 M	USA
Avinger AVGR	1.01 M	-	-20.74 %	$ 369 K	USA
CONMED Corporation CNMD	248 M	$ 34.58	-5.62 %	$ 1.07 B	USA
NanoVibronix NAOV	98 K	-	-	$ 1.08 M	USA
Cytosorbents Corporation CTSO	7.32 M	$ 0.59	-1.18 %	$ 32.1 M	USA
Aethlon Medical AEMD	128 K	$ 2.15	-5.29 %	$ 3.36 M	USA
Edwards Lifesciences Corporation EW	660 M	$ 79.34	-3.36 %	$ 46.4 B	USA
BIOLASE BIOL	5.48 M	-	-13.19 %	$ 166 K	USA
AdaptHealth Corp. AHCO	371 M	$ 11.2	-1.84 %	$ 1.51 B	USA
OrthoPediatrics Corp. KIDS	53.8 M	$ 15.52	-5.08 %	$ 364 M	USA
Invacare Corporation IVC	88 M	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	21 K	-	10.0 %	$ 610 K	USA
Myomo MYO	4.1 M	$ 0.7	2.32 %	$ 29.3 M	USA
Penumbra PEN	190 M	$ 335.1	-0.39 %	$ 13 B	USA
Inspire Medical Systems INSP	120 M	$ 50.13	-0.63 %	$ 1.47 B	USA
Pulmonx Corporation LUNG	12.1 M	$ 1.17	-5.65 %	$ 47.6 M	USA
Cutera CUTR	43.1 M	-	-10.19 %	$ 1.99 M	USA
Eargo EAR	1.91 M	-	-	$ 10.2 M	USA
NuVasive NUVA	249 M	-	-	$ 2.07 B	USA
Nevro Corp. NVRO	71.9 M	-	-	$ 217 M	USA
Surgalign Holdings SRGA	16.1 M	-	-32.98 %	$ 1.68 M	USA
STRATA Skin Sciences SSKN	4.47 M	-	-	$ 6.6 M	USA
GBS GBS	595 K	-	-0.57 %	$ 7.12 M	USA
AVITA Medical RCEL	9.09 M	$ 3.82	-1.04 %	$ 106 M	Australia
AxoGen AXGN	26.2 M	$ 31.28	-3.01 %	$ 1.44 B	USA
Delcath Systems DCTH	11.7 M	$ 8.97	-1.75 %	$ 321 M	USA